Skip to main content

Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view Diasorin's International Product Information.
This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators.

LIAISON NES® FLU A/B, RSV & COVID-19 Assay

Rapid 4-in-1 respiratory detection

From a single patient nasal swab, the LIAISON NES® FLU A/B, RSV & COVID-19 Assay delivers accurate molecular detection of four respiratory pathogens in under 20 minutes to guide timely diagnosis and treatment.

The LIAISON<sup>®</sup> NES Instrument

Disease state

Influenza A, influenza B, RSV and COVID-19 are all contagious respiratory infections that primarily spread through close contact via respiratory droplets as well as through contact with contaminated surfaces. They share overlapping symptoms such as fever, cough, fatigue, sore throat, and body aches, making it difficult to distinguish among them based solely on clinical presentation. These illnesses often follow a similar seasonal pattern (primarily fall and winter), with peak incidence placing significant strain on healthcare systems. 

Vulnerable populations—including infants, older adults, and individuals with chronic conditions—bear the highest risk of severe disease, with complications like pneumonia, and hospitalization. Early diagnosis is key to prevent outbreaks and apply the right treatment.

Influenza A, influenza B, RSV, and COVID-19 are all contagious respiratory infections with similar symptoms and high risk for severe illness in vulnerable groups.

The value of LIAISON NES® FLU A/B, RSV & COVID-19 Assay

Faster personalized care with onsite molecular testing that enables same-visit treatment and clinical decisions, seamless workflows, and real-time data visibility across your entire network.

Better patient outcomes

Reduce infection spread and promote antibiotic stewardship with immediate test-and-treat care.

Efficient workflows

Easy-to-implement molecular testing that minimizes operator time, errors, and manual steps.

Seamless integration

Comprehensive reporting and real-time visibility across multiple sites with the most complete suite of connectivity capabilities.

How LIAISON NES® FLU A/B, RSV & COVID-19 Assay works

The LIAISON NES® FLU A/B, RSV & COVID-19 assay is a real-time RT-PCR test used on the patented LIAISON NES® instrument to detect influenza A, influenza B, RSV, and SARS-CoV-2 viruses in dry nasal swabs.

01

Sample-to-answer point of care

Patient samples are loaded directly into ready-to-use cartridges with no complex preparation, eliminating traditional molecular setup steps. A guided, walk-away workflow transforms advanced testing into a simple, reliable point-of-care experience.

02

Cloud connectivity for multi-site visibility

Cloud connectivity delivers real-time visibility into system performance across locations, supporting proactive service, remote monitoring, and consistent operations across decentralized sites.

Indications for LIAISON NES® FLU A/B, RSV & COVID-19 Assay use

Assay and system

A real-time RT-PCR assay run on the LIAISON NES® to detect influenza A, influenza B, respiratory syncytial virus, and SARS-CoV-2 in one sample

Patient types

Human patients with signs and symptoms of respiratory tract infection in conjunction with clinical and epidemiological risk factors

Healthcare settings

Urgent Care, Physician Practices, Health Systems, and Hospitals across outpatient clinics, labs, and emergency departments

LIAISON NES® FLU A/B, RSV & COVID-19 Assay workflow

Getting respiratory answers should be fast, accurate, and simple.
The LIAISON NES® FLU A/B, RSV & COVID-19 Assay uses an easy 3-step workflow to deliver differential and definitive results within 20 minutes.

Fast, definitive respiratory answers when it matters most

  • Delivers differential results for Flu A, Flu B, RSV, and COVID-19
  • Supports rapid clinical decision-making during high-volume respiratory seasons
  • Enables same-visit diagnosis and treatment planning

Simple workflow built for point-of-care environments

  • Easy, intuitive 3-step workflow designed for busy clinical settings
  • Ready-to-use cartridges eliminate complex sample preparation
  • Minimal hands-on time reduces operator burden and variability
01

Transfer sample

Transfer sample to cartridge.

02

Scan cartridge

Scan the cartridge to automatically open the door.

03

Load and launch

Load the cartridge, initiate the run, and walk away.

To be used on the LIAISON NES® Instrument

The LIAISON NES® system is a novel point-of-care molecular solution where patient samples can be directly loaded into ready-to-use cartridges, simplifying complex laboratory workflows, and producing actionable results within 20 minutes.

LIAISON NES®

LIAISON NES®

Empower faster personalized care with onsite molecular testing that enables same-visit treatment decisions, seamless workflows, and real-time data visibility across your entire network.

Discover more

LIAISON NES® FLU A/B, RSV & COVID-19 Assay ordering info

Part Name
Kit Size
Registration Status
Part Number

LIAISON NES® FLU A/B, RSV & COVID-19 Assay Kit

1

IVD

NES4450

LIAISON NES® FLU A/B, RSV & COVID-19 Control Swab Kit

1

IVD

NES4460

LIAISON NES® Training Kit

1

IVD

NES4470

Resources

Diasorin document repository

Dialog

Luminex document repository

Discover more

Research publications

Discover more

More details about LIAISON NES® FLU A/B, RSV & COVID-19 Assay

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support